11.49
price down icon0.09%   -0.010
after-market After Hours: 11.62 0.13 +1.13%
loading
CorMedix Inc stock is traded at $11.49, with a volume of 1.81M. It is down -0.09% in the last 24 hours and down -23.25% over the past month. CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
See More
Previous Close:
$11.50
Open:
$11.48
24h Volume:
1.81M
Relative Volume:
0.92
Market Cap:
$779.31M
Revenue:
$65,400
Net Income/Loss:
$-46.34M
P/E Ratio:
-12.49
EPS:
-0.92
Net Cash Flow:
$-38.74M
1W Performance:
+5.80%
1M Performance:
-23.25%
6M Performance:
-7.49%
1Y Performance:
+143.95%
1-Day Range:
Value
$11.38
$11.82
1-Week Range:
Value
$10.70
$11.92
52-Week Range:
Value
$3.61
$17.43

CorMedix Inc Stock (CRMD) Company Profile

Name
Name
CorMedix Inc
Name
Phone
908-517-9500
Name
Address
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2025-03-25
Name
Latest SEC Filings
Name
CRMD's Discussions on Twitter

Compare CRMD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRMD
CorMedix Inc
11.49 855.94M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-30-25 Downgrade D. Boral Capital Buy → Hold
Jun-30-25 Initiated H.C. Wainwright Buy
Mar-07-25 Initiated Leerink Partners Outperform
Jan-13-25 Initiated D. Boral Capital Buy
Aug-26-24 Initiated Rodman & Renshaw Buy
Aug-10-23 Initiated RBC Capital Mkts Outperform
Feb-17-21 Initiated Needham Buy
Sep-29-20 Initiated JMP Securities Mkt Outperform
Sep-21-20 Initiated Truist Buy
Dec-18-19 Initiated B. Riley FBR Buy
Mar-26-19 Reiterated H.C. Wainwright Buy
Dec-06-18 Initiated ROTH Capital Buy
Sep-25-17 Reiterated H.C. Wainwright Buy
Aug-10-17 Reiterated Rodman & Renshaw Buy
May-05-17 Reiterated Rodman & Renshaw Buy
Nov-11-16 Reiterated FBR & Co. Outperform
Mar-17-16 Reiterated FBR Capital Outperform
Mar-03-16 Initiated FBR Capital Outperform
Nov-16-15 Reiterated ROTH Capital Neutral
Oct-29-15 Reiterated ROTH Capital Neutral
May-06-15 Downgrade ROTH Capital Buy → Neutral
Dec-08-14 Reiterated ROTH Capital Buy
Oct-03-11 Downgrade Maxim Group Buy → Hold
View All

CorMedix Inc Stock (CRMD) Latest News

pulisher
Jul 26, 2025

Why CorMedix Inc. stock attracts strong analyst attentionFree Stock Market Courses - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives CorMedix Inc. stock priceExceptional earning trajectories - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What makes CorMedix Inc. stock attractive to long term investorsHigh-profit trading signals - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about CorMedix Inc. stockFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Federal judge withdraws opinion after lawyer points out fake quotes, misstated case outcomes - ABA Journal

Jul 24, 2025
pulisher
Jul 24, 2025

CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

NJ Fed. Judge Pulls Opinion Flagged With Nonexistent Quotes - Law360

Jul 24, 2025
pulisher
Jul 23, 2025

Judge Scraps Opinion After Lawyer Flags Made-Up Quotes (Correct) - Bloomberg Law News

Jul 23, 2025
pulisher
Jul 23, 2025

CorMedix Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is CorMedix Inc. a good long term investmentDynamic investment growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 18, 2025

CorMedix Inc. (CRMD) Plunges 1.90% to 2025 Low - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

CorMedix Inc. (CRMD) Stock Analysis: Biotech's Hidden Gem With 71.64% Potential Upside - DirectorsTalk Interviews

Jul 18, 2025
pulisher
Jul 15, 2025

What makes CorMedix Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How CorMedix Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

CorMedix soars on increased Q2 sales guidance - MSN

Jul 14, 2025
pulisher
Jul 14, 2025

Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

(CRMD) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire

Jul 10, 2025
pulisher
Jul 07, 2025

RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18 - 富途牛牛

Jul 07, 2025
pulisher
Jul 02, 2025

Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire

Jul 02, 2025
pulisher
Jul 02, 2025

Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph

Jul 02, 2025
pulisher
Jul 01, 2025

CorMedix Completes $82.2 Million Stock Offering - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

CorMedix stock rating reiterated as Buy by H.C. Wainwright - Investing.com India

Jun 30, 2025
pulisher
Jun 30, 2025

This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday - Benzinga

Jun 30, 2025
pulisher
Jun 27, 2025

CorMedix slides after pricing $85M stock offering - MSN

Jun 27, 2025

CorMedix Inc Stock (CRMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):